Patrick brings over 20 years of biotech expertise, specialising in bioengineering, microbiome modulation, and longevity. With a PhD in Molecular Microbiology from the Biozentrum in Basel, he has held leadership positions at MIT, Sanofi, and Rejuveron, driving advancements in synthetic biology, organoid development, drug discovery, and aging-related diseases, particularly inflammatory conditions. Patrick combines scientific expertise and entrepreneurial vision to develop supplements that precisely modulate human microbiomes, enhancing health and extending lifespan.